Isabelle Daskas, OD | |
4646 John R St, Detroit, MI 48201-1916 | |
(313) 576-1000 | |
Not Available |
Full Name | Isabelle Daskas |
---|---|
Gender | Female |
Speciality | Optometrist |
Location | 4646 John R St, Detroit, Michigan |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1821724030 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
152W00000X | Optometrist | 4901005626 (Michigan) | Primary |
Provider Name | Normandy Optical Company, Inc |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1124189089 PECOS PAC ID: 8325192859 Enrollment ID: O20090819000127 |
News Archive
"World Health Organisation Director-General Margaret Chan announced Tuesday the end of the [H1N1] swine flu pandemic, more than a year after it was declared," Agence France-Presse reports. "The world is no longer in phase 6 of influenza pandemic alert. We are now moving into the post-pandemic period," Chan said during a virtual press conference from Hong Kong, according to a WHO press release (8/10).
A study published in the February 22 issue of Current Biology confirms the influential role of genetics in determining the wide range of human sensitivity to taste, ultimately impacting how we each perceive the world in a slightly different way.
Scientists at the Barbara Ann Karmanos Cancer Institute in Detroit today presented data at the American Association for Cancer Research's 101st Annual Meeting 2010 that shows when genistein, a component of soy, is paired with the FDA-approved drug oxaliplatin, pancreatic cancer cells become more sensitive to chemotherapy.
AngioScore, Inc., a developer of novel angioplasty catheters for use in the treatment of cardiovascular disease, today announced the launch of new, longer AngioSculpt PTA Scoring Balloon Catheters for the treatment of peripheral artery disease.
Twice-yearly intravenous infusion with denosumab, a new targeted therapy to stop bone loss, increased bone density and prevented spinal fractures in men receiving androgen-deprivation therapy for prostate cancer. The report from an international research study, the first to document reduced fracture risk in men receiving the hormone-blocking treatment, was published today in the print edition of the New England Journal of Medicine (NEJM). Both fundamental research on rank ligand (RANKL) in prostate cancer bone metastasis and other molecular factors involved in the denosumab study were supported at Massachusetts General Hospital with funding from the Prostate Cancer Foundation (PCF).
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Isabelle Daskas, OD 5717 Sovereign Dr, Oakland Township, MI 48306-2269 Ph: () - | Isabelle Daskas, OD 4646 John R St, Detroit, MI 48201-1916 Ph: (313) 576-1000 |
News Archive
"World Health Organisation Director-General Margaret Chan announced Tuesday the end of the [H1N1] swine flu pandemic, more than a year after it was declared," Agence France-Presse reports. "The world is no longer in phase 6 of influenza pandemic alert. We are now moving into the post-pandemic period," Chan said during a virtual press conference from Hong Kong, according to a WHO press release (8/10).
A study published in the February 22 issue of Current Biology confirms the influential role of genetics in determining the wide range of human sensitivity to taste, ultimately impacting how we each perceive the world in a slightly different way.
Scientists at the Barbara Ann Karmanos Cancer Institute in Detroit today presented data at the American Association for Cancer Research's 101st Annual Meeting 2010 that shows when genistein, a component of soy, is paired with the FDA-approved drug oxaliplatin, pancreatic cancer cells become more sensitive to chemotherapy.
AngioScore, Inc., a developer of novel angioplasty catheters for use in the treatment of cardiovascular disease, today announced the launch of new, longer AngioSculpt PTA Scoring Balloon Catheters for the treatment of peripheral artery disease.
Twice-yearly intravenous infusion with denosumab, a new targeted therapy to stop bone loss, increased bone density and prevented spinal fractures in men receiving androgen-deprivation therapy for prostate cancer. The report from an international research study, the first to document reduced fracture risk in men receiving the hormone-blocking treatment, was published today in the print edition of the New England Journal of Medicine (NEJM). Both fundamental research on rank ligand (RANKL) in prostate cancer bone metastasis and other molecular factors involved in the denosumab study were supported at Massachusetts General Hospital with funding from the Prostate Cancer Foundation (PCF).
› Verified 5 days ago
Dr. Robert Fredrick Lee Iii, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 15157 Gratiot Ave, Detroit, MI 48205 Phone: 313-526-7664 Fax: 313-526-2055 | |
Dr. Sura Hassan, OD Optometrist Medicare: Medicare Enrolled Practice Location: 4717 St. Antoine, Kresge Eye Institute, Detroit, MI 48201 Phone: 313-577-8900 Fax: 313-577-0700 | |
Dr. Richard Edwin Gay, OD Optometrist Medicare: Medicare Enrolled Practice Location: 19173 Mack Ave, Detroit, MI 48230 Phone: 313-882-7883 Fax: 313-882-5128 | |
Heritage Optical Inc. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2678 E Jefferson Ave, Detroit, MI 48207 Phone: 313-259-6006 | |
Dr. Linda Le, Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1301 Orleans St Apt 1705, Detroit, MI 48207 Phone: 248-759-9202 | |
Wayne State University Physician Group Optometrist Medicare: Not Enrolled in Medicare Practice Location: 4717 Saint Antoine St, Detroit, MI 48201 Phone: 313-577-8900 Fax: 313-577-0700 | |
Heritage Optical Center, Inc. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 19010 Livernois Ave, Detroit, MI 48221 Phone: 313-863-9581 |